“…These regulatory elements reside in developmentally regulated and tissue-specific nuclear DNase I-hypersensitive sites (DHSs) (4,23,24,26,37,39,47) and are accessible for binding transcription factors in vivo (23,24,26,39). The characterization of promoter sequences in the absence of enhancer or LCR elements has defined transcription factor binding sites which are required for the modulation of both promoter activity and promoter function (5,6,11,12,14,18,23,32,38,44) and which may mediate putative promoter-enhancer-LCR interactions (1,2,7,8,10,16,28,29,35,48,50).…”